157 related articles for article (PubMed ID: 37186071)
21. Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.
Taskinen S; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2018 Aug; 53(8):1611-1614. PubMed ID: 29074135
[TBL] [Abstract][Full Text] [Related]
22. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
23. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
[TBL] [Abstract][Full Text] [Related]
24. Staging problems in the pre-operative chemotherapy of Wilms' tumour.
Zoeller G; Pekrun A; Lakomek M; Ringert RH
Br J Urol; 1995 Oct; 76(4):501-3. PubMed ID: 7551893
[TBL] [Abstract][Full Text] [Related]
25. Near complete resolution of refractory, relapsed, metastatic Wilms' tumour in an adolescent with bevacizumab.
Kumar S; Burney IA; Al-Moundhri MS
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S71-2. PubMed ID: 24718015
[TBL] [Abstract][Full Text] [Related]
26. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
27. Risks and benefits of percutaneous biopsy and primary chemotherapy in advanced Wilms' tumour.
Dykes EH; Marwaha RK; Dicks-Mireaux C; Sams V; Risdon RA; Duffy PG; Ransley PG; Pritchard J
J Pediatr Surg; 1991 May; 26(5):610-2. PubMed ID: 1648128
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic therapy for Wilms tumor in an adult and literature review.
Wang J; Fan S; Feng Y; Zhang H; Zou W; Hu C
Anticancer Drugs; 2019 Jul; 30(6):640-645. PubMed ID: 30985306
[TBL] [Abstract][Full Text] [Related]
31. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
32. Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer.
Coelho SM; Vaisman M; Carvalho DP
Curr Pharm Des; 2005; 11(19):2525-31. PubMed ID: 16026305
[TBL] [Abstract][Full Text] [Related]
33. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
34. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
35. S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor.
Li MH; Sanchez T; Milne GL; Morrow JD; Hla T; Ferrer F
J Urol; 2009 Mar; 181(3):1347-52. PubMed ID: 19157443
[TBL] [Abstract][Full Text] [Related]
36. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
37. Wilms tumour: diagnosis and treatment.
Coppes MJ; Wolff JE; Ritchey ML
Paediatr Drugs; 1999; 1(4):251-62. PubMed ID: 10935424
[TBL] [Abstract][Full Text] [Related]
38. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.
Powis M; Messahel B; Hobson R; Gornall P; Walker J; Pritchard-Jones K
J Pediatr Surg; 2013 Nov; 48(11):2181-6. PubMed ID: 24210183
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
40. Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study.
Droz D; Rousseau-Merck MF; Jaubert F; Diebold N; Nezelof C; Adafer E; Mouly H
Hum Pathol; 1990 May; 21(5):536-44. PubMed ID: 1692563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
